4.3 Article

Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Global burden of heart failure: a comprehensive and updated review of epidemiology

Gianluigi Savarese et al.

Summary: Heart Failure (HF) is a multi-faceted and life-threatening syndrome with significant morbidity and mortality worldwide, affecting over 64 million people. While the incidence of HF has stabilized in industrialized countries, the prevalence is increasing due to population ageing and improved treatment. Developing countries lack substantial data on HF epidemiology, which shows different features compared to the Western world. This review provides updated estimates on global burden of HF including prevalence, incidence, outcomes, and costs.

CARDIOVASCULAR RESEARCH (2022)

Article Biochemistry & Molecular Biology

The Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress

Kazuaki Maruyama et al.

Summary: Fibrosis is the excessive deposition of extracellular matrix (ECM) proteins in the interstitium, which is a pathological response to chronic inflammation. Although initially protective, excessive and continuous tissue damage and deposition lead to distorted organ structure and significant impact on cardiac function. This review summarizes the histologic features of cardiac fibrosis, the signaling factors that control it, the origin and characteristic markers of cardiac fibroblasts, and the growing importance of lymphatic vessels in improving cardiac fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Plant Sciences

YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI3K/AKT/mTOR pathway

Meixu Wan et al.

Summary: The Yiqi Fumai lyophilized injection (YQFM) demonstrated protective effects in cardiac hypertrophy by inhibiting cardiomyocyte apoptosis, regulating autophagy pathway, and activating the PI3K/AKT/mTOR pathway to attenuate cardiac hypertrophy.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Article Gastroenterology & Hepatology

AXL Is a Potential Target for the Treatment of Intestinal Fibrosis

Calen A. Steiner et al.

Summary: The AXL pathway is activated in multiple models of intestinal fibrosis, and inhibiting AXL signaling with a small molecule inhibitor has shown promising results in reducing fibrogenesis and sensitizing myofibroblasts to apoptosis. Inhibition of AXL also blocks the expression of fibrogenic genes and proteins in human intestinal organoids, suggesting a potential novel approach to antifibrotic therapy for intestinal fibrosis such as in Crohn's disease.

INFLAMMATORY BOWEL DISEASES (2021)

Article Cardiac & Cardiovascular Systems

Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice

Peng Chen et al.

Summary: The study found that liraglutide can reduce blood pressure and blood sugar in hypertensive mice, inhibit cardiac fibrosis, and decrease AT1R expression and ROS generation.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2021)

Article Medicine, General & Internal

L-carnitine treatment attenuates renal tubuloint-erstitial fibrosis induced by unilateral ureteral obstruction

Hai Yan Zhao et al.

Summary: L-carnitine (LC) provides renoprotection in a rat model of unilateral ureteral obstruction by inhibiting inflammation, reducing fibrosis, regulating oxidative stress and apoptosis, and modulating the PI3K/AKT/FoxO1a signaling pathway.

KOREAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Medicine, Research & Experimental

L-carnitine protects cardiac damage by reducing oxidative stress and inflammatory response via inhibition of tumor necrosis factor-alpha and interleukin-1beta against isoproterenol-induced myocardial infarction

Tushar Emran et al.

Summary: The study demonstrated that L-carnitine plays a protective role against cardiac and renal damage in ISO-treated MI rat model by suppressing oxidative stress, increasing antioxidant enzyme functions, and inhibiting TNF-alpha and IL-1 beta.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease

Abbasin Zegard et al.

Summary: In patients with coronary artery disease, assessment of myocardial fibrosis along with quantification of GZF mass is more strongly predictive of sudden cardiac death and ventricular arrhythmias than left ventricular ejection fraction. This approach may be preferred in selecting patients for implantable cardioverter-defibrillators.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Oncology

Matrix metalloproteinase 3 regulates angiotensin II-induced myocardial fibrosis cell viability, migration and apoptosis

Jin Shu et al.

Summary: The study showed that MMP3 knockdown altered myocardial fibroblast cell viability, migration, and apoptosis by regulating apoptosis- and oxidative stress-related genes, thus delaying MF progression.

MOLECULAR MEDICINE REPORTS (2021)

Article Cell Biology

Hydrogen Sulfide Attenuates Angiotensin II-Induced Cardiac Fibroblast Proliferation and Transverse Aortic Constriction-Induced Myocardial Fibrosis through Oxidative Stress Inhibition via Sirtuin 3

Lulu Liu et al.

Summary: Hydrogen sulfide attenuates myocardial fibrosis through oxidative stress inhibition in a SIRT3-dependent manner.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Biotechnology & Applied Microbiology

Bcl-2 Is Involved in Cardiac Hypertrophy throu PI3K-Akt Pathway

Xianwei Meng et al.

Summary: This study identified key pathways and downstream effectors related to cardiac hypertrophy through gene expression profile analysis. It revealed that the PI3K-Akt signaling pathway plays a crucial role in cardiac hypertrophy, with Bcl-2 identified as a key downstream effector. These findings suggest Bcl-2 as a potential therapeutic target in the clinical management of cardiac hypertrophy.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Cell Biology

Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene

Shengqi Huo et al.

Summary: In this study, inflammation and IL-6/STAT3 signaling were found to be activated in pressure overload-induced heart failure (HF) in mice. Prolonged IL-6 stimulation also induced oxidative stress and an increase in mitophagy-related proteins in H9c2 myoblasts, all of which were inhibited by raloxifene. These findings suggest that IL-6/STAT3 signaling may play a role in the pathogenesis of myocardial hypertrophy and HF.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Article Biotechnology & Applied Microbiology

Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/transforming growth factor-beta (TGF-beta 1)/Smad axis

Youquan Chen et al.

Summary: Tranilast exerts its ameliorative effect on myocardial fibrosis by inhibiting the S100A11/TGF-beta 1/Smad axis, thus providing a new research direction for the treatment of cardiac fibrosis.

BIOENGINEERED (2021)

Article Health Care Sciences & Services

Levels of Apelin-12, AT1R, and AGT are correlated with degree of renal fibrosis in patients with immunoglobulin A nephropathy

Qiao-Ying Wu et al.

Summary: The study found that Apelin-12 levels decrease with disease progression, while AT1R and AGT levels increase. Changes in levels of Apelin-12, AT1R, and AGT are significant in judging the degree of renal fibrosis in patients with IgA nephropathy, with AGT levels showing the highest correlation with the degree of renal fibrosis.

ANNALS OF PALLIATIVE MEDICINE (2021)

Article Biochemistry & Molecular Biology

Reprint of The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking

Arantxa Gonzalez et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)

Review Biochemistry & Molecular Biology

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

Griselda A. Cabral-Pacheco et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

STAT4: an immunoregulator contributing to diverse human diseases

Chou Yang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking

Arantxa Gonzalez et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)

Article Medicine, Research & Experimental

Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells

Dongxiao Meng et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Biochemistry & Molecular Biology

Caspase-3 Mediated Cell Death in the Normal Development of the Mammalian Cerebellum

Laura Lossi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Cardiac & Cardiovascular Systems

Myocardial fibrosis: biomedical research from bench to bedside

Mariann Gyoengyoesi et al.

EUROPEAN JOURNAL OF HEART FAILURE (2017)

Review Cardiac & Cardiovascular Systems

Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis

J. Neefs et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Oncology

Periostin cross-reacts with the renin-angiotensin system during liver fibrosis development

Kosuke Takeda et al.

MOLECULAR MEDICINE REPORTS (2017)

Article Multidisciplinary Sciences

TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice

Nina D. Thiele et al.

SCIENTIFIC REPORTS (2017)

Article Engineering, Biomedical

Higher levels of matrix metalloproteinase-3 in patients with RA reflect disease activity and structural damage

Martina Skacelova et al.

BIOMEDICAL PAPERS-OLOMOUC (2017)

Article Endocrinology & Metabolism

Molecular and cellular mechanisms of glucagon-like peptide-I receptor agonist-mediated attenuation of cardiac fibrosis

Tracey Gaspari et al.

DIABETES & VASCULAR DISEASE RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

STAT4 deficiency reduces the development of atherosclerosis in mice

Paresa L. Taghavie-Moghadam et al.

ATHEROSCLEROSIS (2015)

Review Biochemistry & Molecular Biology

The pathogenesis of cardiac fibrosis

Ping Kong et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

Review Biochemistry & Molecular Biology

Cytokine functions of TIMP-1

Christian Ries

CELLULAR AND MOLECULAR LIFE SCIENCES (2014)

Article Medicine, General & Internal

Levocarnitine Protects H9c2 Rat Cardiomyocytes from H2O2-induced Mitochondrial Dysfunction and Apoptosis

Cui-Ying Mao et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)

Article Pathology

Regulation and Role of Connective Tissue Growth Factor in AngII-Induced Myocardial Fibrosis

Nicole L. Rosin et al.

AMERICAN JOURNAL OF PATHOLOGY (2013)

Review Genetics & Heredity

Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease

Jun Ren et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2010)

Review Urology & Nephrology

Role of angiotensin II AT1 receptor activation in cardiovascular diseases

Sandrine Billet et al.

KIDNEY INTERNATIONAL (2008)

Review Pharmacology & Pharmacy

Induction of cardiac fibrosis by angiotensin II

PJ Lijnen et al.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2000)